Cite
HARVARD Citation
Fine, S. et al. (n.d.). S780 Outcomes for Patients With IBD and Discontinuation of Biologic Therapy Due to Primary vs SLR and Then Treated With Ustekinumab. American journal of gastroenterology. p. S361. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fine, S. et al. (n.d.). S780 Outcomes for Patients With IBD and Discontinuation of Biologic Therapy Due to Primary vs SLR and Then Treated With Ustekinumab. American journal of gastroenterology. p. S361. [Online].